Neonatal hyperglycaemia is a condition where newborn babies have unusually high blood sugar levels during the first days of life, and while it occurs less frequently than low blood sugar in newborns, it requires careful medical attention because it can increase the risk of serious health complications.

What is Neonatal Hyperglycaemia

When a baby is born, their body needs to adjust to life outside the womb, including managing blood sugar levels on their own. Neonatal hyperglycaemia occurs when a newborn’s blood sugar rises too high during the first days or weeks of life. This condition is defined as having a blood glucose concentration greater than 150 milligrams per deciliter in blood taken from a vein, or greater than 125 milligrams per deciliter in whole blood, regardless of how early or late the baby was born.^[1]

The safe range for a newborn’s blood sugar is generally between 70 and 150 milligrams per deciliter. When blood sugar rises above these levels, medical teams need to take action because high glucose can lead to complications. This threshold is based on the ability of a premature baby’s kidneys to handle glucose without allowing too much to spill into the urine.^[6]

Although neonatal hyperglycaemia is less common than neonatal hypoglycaemia (low blood sugar), it is still an important condition that healthcare providers watch for carefully. The condition matters because it can increase both illness and death rates among newborns who develop it, particularly when it results from or complicates other underlying health problems.^[1]

Epidemiology

Neonatal hyperglycaemia occurs more frequently in babies born prematurely than in those born at full term. The condition typically appears during the first week of life, with most cases developing within the first few days after birth. For many newborns, the high blood sugar resolves within two to three days, though in some cases it can persist for up to ten days.^[6]

The risk of developing hyperglycaemia is directly related to how small and how premature a baby is. In very low birth weight infants, those weighing less than 1.5 kilograms, the prevalence of hyperglycaemia ranges from 40 to 80 percent. This means that nearly half to most of these tiny babies will experience episodes of high blood sugar at some point during their early hospital stay.^[5]

The condition occurs more frequently in extremely premature infants and those with extremely low birth weights. About one in three to one in two very low birth weight babies will develop hyperglycaemia during their time in the neonatal intensive care unit. The smaller the baby and the earlier they are born, the higher the likelihood that they will experience this blood sugar imbalance.^[6]

Causes

The most common cause of neonatal hyperglycaemia is iatrogenic, meaning it results from medical treatment itself. This typically happens when intravenous fluids containing glucose (sugar water) are given too quickly or at too high a concentration during the first few days of life. Very low birth weight infants, those weighing less than 1.5 kilograms, are particularly vulnerable to this type of hyperglycaemia because their tiny bodies cannot process glucose as efficiently as larger, full-term babies.^[1]

Another major cause is physiological stress that the newborn experiences. Situations such as surgery, lack of oxygen, respiratory distress syndrome, or serious infections called sepsis can trigger high blood sugar levels. Fungal sepsis poses a particularly high risk for causing hyperglycaemia. When babies experience these stressful conditions, their bodies release stress hormones that interfere with normal blood sugar control.^[1]

In premature infants, the body’s insulin system may not be fully developed. These babies can have problems converting proinsulin (the inactive form) into active insulin, and they may also experience insulin resistance, where their cells don’t respond properly to insulin even when it is present. Both of these issues make it difficult for premature babies to keep their blood sugar at healthy levels.^[1]

Certain medical treatments can also cause hyperglycaemia in newborns. Corticosteroid therapy, which is sometimes needed to treat other conditions, can raise blood sugar levels. Additionally, medications such as dopamine, dobutamine, and epinephrine infusions, as well as caffeine and theophylline, can contribute to high blood sugar. Even some medications given to the mother before birth, such as diazoxide, can cause hyperglycaemia in the newborn.^[6]

Feeding practices in the neonatal intensive care unit can influence blood sugar levels as well. When babies experience delays in starting feeds, their bodies produce less of certain hormones called incretins that help control blood sugar. Similarly, when babies receive nutrition through intravenous lines rather than through feeding, imbalances in the nutrients provided can lead to high blood sugar. High rates of lipid infusion can increase free fatty acids in the blood, which interfere with the body’s ability to use glucose properly.^[6]

A rare but important cause is transient neonatal diabetes mellitus, a temporary form of diabetes that usually occurs in babies who are small for their gestational age. This condition is self-limited, meaning it goes away on its own, typically within a few weeks of life. Unlike permanent diabetes, this temporary form resolves without long-term treatment in most cases.^[1]

Risk Factors

The strongest risk factor for developing neonatal hyperglycaemia is prematurity. Babies born before their due date, especially those born very early, face significantly higher risks because their bodies are not yet fully prepared to regulate blood sugar on their own. The relationship is clear: the earlier a baby is born and the lower their birth weight, the greater the chance they will develop high blood sugar during their hospital stay.^[6]

Very low birth weight, defined as weighing less than 1.5 kilograms at birth, is a major risk factor. These tiny babies have immature organ systems, including underdeveloped pancreases that cannot produce adequate insulin. Their small body mass also means they have less muscle tissue to absorb and use glucose, contributing to the buildup of sugar in their bloodstream.^[1]

Babies who experienced intrauterine growth restriction, meaning they did not grow properly in the womb, are at increased risk. These babies are often born smaller than expected for their gestational age and may have metabolic imbalances that make blood sugar control more difficult. Intrauterine growth restriction can result from problems with the placenta, maternal health conditions, or other factors that limit nutrients reaching the developing baby.^[6]

Newborns who are critically ill or experiencing medical stress face higher risks of hyperglycaemia. Babies undergoing surgery, those with severe breathing difficulties, or those requiring medications to support their blood pressure are all at increased risk. The stress response triggers hormone releases that push blood sugar levels upward as part of the body’s attempt to provide energy for healing.^[1]

Babies who develop infections, particularly serious bloodstream infections or fungal infections, are more likely to experience hyperglycaemia. Sepsis creates significant metabolic disturbances throughout the body, and high blood sugar often appears as one of many signs that the baby is fighting a serious infection. Fungal sepsis presents an especially high risk for causing persistent hyperglycaemia.^[1]

Newborns receiving high rates of intravenous glucose or those who experience errors in the calculation of their glucose infusion rate are at risk for iatrogenic hyperglycaemia. Similarly, babies receiving total parenteral nutrition, where all nutrients are delivered intravenously, face increased risk, particularly if the balance of nutrients is not optimal or if lipid infusions are given at high rates.^[6]

Symptoms

One of the challenging aspects of neonatal hyperglycaemia is that newborn babies do not show specific symptoms that point directly to high blood sugar. Instead, the signs and symptoms that healthcare providers observe are typically those of the underlying condition causing the hyperglycaemia, whether that is an infection, respiratory distress, or another medical problem.^[1]

When blood sugar levels become very high, some glucose begins to spill into the urine, a condition called glycosuria. This can lead to increased urination, which parents or nurses might notice as more frequent wet nappies than expected. The excess urination occurs because the kidneys are trying to eliminate the extra sugar from the body by flushing it out in urine.^[6]

The increased urination caused by high blood sugar can lead to dehydration if not addressed. Babies may lose important fluids and electrolytes through this osmotic process, where sugar in the urine pulls water along with it. Healthcare providers monitor babies carefully for signs of dehydration, which can include decreased skin elasticity, dry mucous membranes, or changes in vital signs.^[1]

In some cases, very high blood sugar levels can cause the blood to become too concentrated, a condition called hyperosmolarity. This means there are too many dissolved particles in the blood, which can draw water out of cells and tissues. While osmotic changes in the brain are rarely seen with glucose levels below 20 millimoles per liter, healthcare providers remain vigilant because severe hyperosmolarity can lead to serious complications.^[5]

Rather than causing obvious symptoms on its own, hyperglycaemia often appears as an abnormal laboratory finding during routine monitoring of sick or premature newborns. Medical teams regularly check blood glucose levels in vulnerable babies specifically to catch hyperglycaemia early, before it can contribute to complications or signal that an underlying condition is worsening.^[1]

Prevention

Preventing neonatal hyperglycaemia begins with careful management of intravenous glucose administration in premature and very low birth weight infants. Healthcare providers should limit the maximum glucose infusion rate to 12 milligrams per kilogram per minute. While premature babies require at least 6 milligrams per kilogram per minute of glucose, and an additional 2 to 3 milligrams per kilogram per minute helps promote protein building, going beyond 12 milligrams per kilogram per minute exceeds the baby’s ability to process the glucose and can lead to hyperglycaemia.^[5]

Accurate calculation of glucose infusion rates is essential to prevent iatrogenic hyperglycaemia. Medical teams must carefully compute how much glucose a baby is receiving through all intravenous sources, including maintenance fluids and nutrition solutions. Even small calculation errors can result in a baby receiving more glucose than their immature system can handle, particularly in the smallest and most premature infants.^[6]

Early initiation of feeding, when medically appropriate, can help prevent hyperglycaemia by stimulating the natural release of hormones that help regulate blood sugar. Delayed feeding can reduce incretin secretion, which in turn can contribute to higher blood sugar levels. However, feeding decisions must always be made based on the individual baby’s medical condition and readiness to tolerate feeds.^[6]

When providing total parenteral nutrition, ensuring appropriate timing and balance of nutrients can help prevent hyperglycaemia. Early supplementation with amino acids in nutrition solutions supports the development of insulin-producing cells in the pancreas. Additionally, avoiding excessively high lipid infusion rates helps prevent the accumulation of free fatty acids that can interfere with glucose metabolism.^[6]

Careful monitoring of babies receiving medications known to raise blood sugar allows healthcare providers to anticipate and prevent severe hyperglycaemia. When corticosteroids, certain blood pressure support medications, or other drugs that affect glucose metabolism are necessary, increased vigilance in checking blood sugar levels enables early detection and intervention before levels become dangerously high.^[6]

Preventing and promptly treating infections in the neonatal intensive care unit reduces the risk of stress-induced hyperglycaemia. Good infection control practices, careful attention to sterile technique when placing intravenous lines, and early recognition of signs of infection all contribute to reducing the metabolic stress that can trigger high blood sugar in vulnerable newborns.^[1]

Pathophysiology

Understanding how neonatal hyperglycaemia develops requires looking at the immature systems in newborn babies, particularly those born prematurely. In premature infants, the insulin-producing beta cells in the pancreas are not fully developed. These cells have difficulty converting proinsulin, the inactive precursor, into active insulin that the body can use to lower blood sugar. This partial defect in insulin processing means that even when the pancreas tries to respond to high glucose levels, it cannot produce enough functioning insulin to do the job effectively.^[1]

Beyond problems with insulin production, premature babies also experience insulin resistance. This means that even when some insulin is present in the bloodstream, the body’s cells do not respond to it as they should. The muscles, liver, and other tissues that normally take up glucose in response to insulin signals fail to do so efficiently. This resistance is partly due to the immaturity of glucose transport systems that move sugar from the blood into cells where it can be used for energy.^[1]

Premature infants also have a reduced ability to suppress glucose production in the liver. In healthy individuals, when blood sugar rises, the liver stops making new glucose and instead stores excess sugar. However, in premature babies, particularly those who experienced intrauterine growth restriction, this shut-off mechanism does not work properly. The liver continues producing glucose even when blood sugar is already too high, compounding the problem.^[6]

The small muscle mass in premature infants contributes significantly to hyperglycaemia. Muscles are major consumers of glucose in the body, and they represent much of the insulin-responsive tissue that normally helps clear sugar from the bloodstream. Tiny premature babies simply do not have enough muscle tissue to absorb and use the glucose being provided, even at rates that would be appropriate for larger babies.^[5]

When babies experience stress from illness, surgery, pain, or other medical conditions, their bodies release stress hormones including epinephrine, norepinephrine, and glucagon. These hormones serve a protective purpose by mobilizing energy stores, but they work against blood sugar control. Epinephrine and norepinephrine both inhibit insulin secretion and reduce insulin’s effectiveness at lowering blood sugar. Meanwhile, glucagon actively promotes the breakdown of stored carbohydrates in the liver, releasing even more glucose into the bloodstream through a process called glycogenolysis.^[6]

The kidneys play an important role in the body’s attempt to manage high blood sugar. Normally, the kidneys filter glucose from the blood and then reabsorb nearly all of it back into the bloodstream through structures called proximal tubules. However, when blood glucose rises above a certain threshold, the reabsorption system becomes overwhelmed. In premature infants, this threshold is lower than in older children and adults because the tubular reabsorption mechanism is not as efficient. Glucose begins spilling into the urine when blood levels exceed approximately 12 to 13 millimoles per liter, though the exact point varies among individual babies.^[5]

When significant amounts of glucose appear in the urine, it creates an osmotic effect, pulling water along with it. Interestingly, premature kidneys handle water and dissolved substances separately. Rather than simply losing large amounts of water along with the glucose, the kidneys reduce free water excretion in an attempt to maintain normal blood concentration. This protective mechanism helps explain why severe osmotic changes are relatively uncommon despite the presence of hyperglycaemia, though the balance can be disrupted if glucose levels become extremely high.^[5]

Each 1 millimole per liter increase in blood glucose raises the osmolality, or concentration, of the blood by 1 millimole per liter. This mathematical relationship means that very high glucose levels can significantly increase blood osmolality, potentially reaching levels that affect brain function and other organs. However, osmolar complications typically do not occur until blood glucose exceeds 20 millimoles per liter, providing some margin of safety as long as hyperglycaemia is detected and treated promptly.^[5]